The transcription factor YY1 is overexpressed in prostate [146], colon [147], liver [148], lung [149], and breast cancers [150], and its over-expression is associated with poor prognosis in patients with osteosarcoma and Acute Lymphoblastic Leukemia [151,152]. Here, YY1 is linked to breast cancer.